Evaluation of miR-122 and Other Biomarkers in Distinct Acute Liver Injury in Rats

Toxicologic Pathology

Volumn 41, Issue 5, 2013, Pages 795-804

  Starckx, Sofie ^a   Batheja, Ameesha ^b   Verheyen, Geert R ^a   Jonghe, Sandra de ^a   Steemans, Kristel ^a   Dijck, Bram Van ^a   Singer, Monica ^b   Bogdan, Nancy ^b   Snoeys, Jan ^a   Vinken, Petra ^a   Sasaki, Jennifer C ^b   Gompel, Jacky Van ^a   Guzzie Peck, Peggy ^b   Lampo, Ann ^a   Lammens, Lieve ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

ALT; biomarker; hepatotoxicity; liver injury; miR 122; rat

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALLYL ALCOHOL; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; DOXORUBICIN; GAMMA GLUTAMYLTRANSFERASE; GLUTAMATE DEHYDROGENASE; GLUTATHIONE TRANSFERASE ALPHA; IDITOL DEHYDROGENASE; MICRORNA 122; PARACETAMOL; PHENOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HISTOPATHOLOGY; LIVER HYPERTROPHY; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ALT; BIOMARKER; HEPATOTOXICITY; LIVER INJURY; MIR-122; RAT.;

ACETAMINOPHEN; ANIMALS; BIOLOGICAL MARKERS; DRUG-INDUCED LIVER INJURY; ISOCYANATES; LIVER; MALE; MICRORNAS; NAPHTHALENES; PROPANOLS; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS, ACUTE;

RATTUS;

EID: 84875846434     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312464436     Document Type: Article

References (28)

1. AVMA. (2007). Guidelines on euthanasia (formerly report of the AVMA panel on euthanasia) JAVMA 218, 669–96.
2. Amar P. J. Schiff E. R. (2007). Acetaminophen safety and hepatotoxicity – where do we go from here? Expert Opin Drug Saf 6, 341–55.
3. Assis D. N. Navarro V. J. (2009). Human drug hepatotoxicity: a contemporary clinical perspective. Expert Opin Drug Metab Toxicol 5, 463–73.
4. Atzori L. Dore M. Congiu L. (1989). Aspects of allyl alcohol toxicity. Drug Metabol Drug Interact 7, 295–319.
5. Belgian Law (October 18, 1991): Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes. Royal Decree of November 14, 1993 for the protection of laboratory animals.
6. Chang C. Y. Schiano T. D. (2007). Review article: Drug hepatotoxicity. Aliment Pharmacol Therapeut 25, 1135–51.
7. Crampton R. F. Gray T. J. Grasso P. Parke D. V. (1977). Long-term studies on chemically induced liver enlargement in the rat. I. Sustained induction of microsomal enzymes with absence of liver damage on feeding phenobarbitone or butylated hydroxytoluene. Toxicology 7, 289–306.
8. Giffen P. S. Pick C. R. Price M. A. Williams A. York M. J. (2002). Alpha-glutathione S-transferase in the assessment of hepatotoxicity – its diagnostic utility in comparison with other recognized markers in the Wistar Han rat. Toxicol Pathol 30, 365–72.
9. Kerr T. A. Korenblat K. M. Davidson N. O. (2011). MicroRNAs and liver disease. Transl Res 157, 241–52.
10. Kossor D. C. Meunier P. C. Handler J. A. Sozio R. S. Goldstein R. S. (1993). Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administration. Toxicol Appl Pharmacol 119, 108–14.
11. Laterza O. F. Lim L. Garrett-Engele P. W. Vlasakova K. Muniappa N. Tanaka W. K. Johnson J. M. Sina J. F. Fare T. L. Sistare F. D. Glaab W. E. (2009). Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55, 1977–83.
12. Lewis A. P. Jopling C. L. (2010). Regulation and biological function of the liver-specific miR-122. Biochem Soc Trans 38, 1553–57.
13. P.P.S., Lewis, J., Dear, V., Platt, K.J., Simpson, D.D.N., Craig, D.J., Antoine, N.S., French, N., Dhaun, D.J., Webb, E.M., Costello, J.P., Neoptolemos, J., Moggs, C.E., Goldring, B.K., Park, Circulating microRNAs as potential markers of human drug-induced liver injury, Hepatology, (2011), 54, 1767-1776
14. Li Z. Y. Xi Y. Zhu W. N. Zeng C. Zhang Z. Q. Guo Z. C. Hao D. L. Liu G. Feng L. Chen H. Z. Chen F. Lv X. Liu D. P. Liang C. C. (2011). Positive regulation of hepatic miR-122 expression by HNF4α. J Hepatol 55, 602–611.
15. Livak K. J. Schmittgen T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408.
16. P.S., Mitchell, R.K., Parkin, E.M., Kroh, B.R., Fritz, S.K., Wyman, E.L., Pogosova-gadjanyan, A., Peterson, J., Noteboom, K.C., O’Briant, A., Allen, D.W., Lin, N., Urban, C.W., Drescher, B.S., Knudsen, D.L., Stirewalt, R., Gentleman, R.L., Vessella, P.S., Nelson, D.B., Martin, M., Tewari, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA, (2008), 105, 10513-10518
17. O’Brien P. J. Slaughter M. R. Polley S. R. Kramer K. (2002). Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats. Lab Anim 36, 313–21.
18. Orsler D. J. Ahmed-Choudhurry J. Chipman J. K. Hammond T. Coleman R. (1999). ANIT-disruption of biliary function in rat hepatocyte couplets. Toxicol Sci 47, 203–10.
19. Ozer J. S. Chetty R. Kenna G. Palandra J. Zhang Y. Lanevschi A. Koppiker N. Souberbielle B. E. Ramaiah S. K. (2010). Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury. Regulatory Toxicology & Pharmacology 56, 237–46.
20. Ozer J. Ratner M. Shaw M. Bailey W. Schomaker S. (2008). The current state of serum biomarkers of hepatotoxicity. Toxicology 245, 194–205.
21. Pelsers M. Hermens W. Glatz J. (2005). Fatty acid-bindings proteins as plasma markers of tissue injury. Clinica Chimica Acta 352, 15–35.
22. Pelsers M. Morovat A. Alexander G. Hermens W. Trull A. Glatz J. (2002), Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients, Clin Chem 48, 2055–57.
23. Ramaiah S. (2007). A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters. Food Chem Toxicol 45, 1551–57.
24. Robert J. (2007). Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: Predictiveness and pitfalls. Cell Biol Toxicol 23, 27–37.
25. Wang K. Zhang S. Marzolf B. Troisch P. Brightman A. Hu Z. Hood L. E. Galas D. J. (2009). Circulating microRNAs, potential biomarkers for drug-induced liver injury. PNAS 106, 4402–07.
26. Wetmore B. A. Brees D. J. Singh R. Watkins P. B. Andersen M. E. Loy J. Thomas R. S. (2010). Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury. Hepatology 51, 2127–39.
27. Yang X. Greenhaw J. Shi Q. Su Z. Qian F. Davis K. Mendrick D. L. Salminen W. F. (2012). Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity. Toxicol Sci 125, 335–44.
28. Zhang Y. Jia Y. Zheng R. Guo Y. Wang Y. Guo H. Fei M. Sun S. (2010). Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56, 1830–838.